News, October 17, 2005 FDA Approvals: Aromasin, Norvir, Helixate/Kogenate FS The FDA has approved a new indication for exemestane tablets (Aromasin), pediatric dosing guidelines for ritonavir ...

Now, a third drug — the aromatase inhibitor exemestane (Aromasin) — has entered the scene. Women were randomized to receive exemestane for as long as 5 years; all women underwent annual ...